Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by GlaxoSmithKline
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01342952
First received: April 26, 2011
Last updated: January 16, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2024
  Estimated Primary Completion Date: October 2022 (Final data collection date for primary outcome measure)